Your browser doesn't support javascript.
loading
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial.
Levallet, Guénaëlle; Dubois, Fatéméh; Elie, Nicolas; Creveuil, Christian; Brosseau, Solenn; Danel, Claire; Scherpereel, Arnaud; Lantuejoul, Sylvie; Mazières, Julien; Greillier, Laurent; Audigier-Valette, Clarisse; Bergot, Emmanuel; Moro-Sibilot, Denis; Molinier, Olivier; Léna, Hervé; Monnet, Isabelle; Morin, Franck; Gounant, Valérie; Zalcman, Gérard.
Affiliation
  • Levallet G; Université de Caen-Normandie, CNRS, Normandie Univ, ISTCT UMR6030, GIP Cyceron, F-14000 Caen, France; Department of Pathology, Caen University Hospital, Caen, France.
  • Dubois F; Université de Caen-Normandie, CNRS, Normandie Univ, ISTCT UMR6030, GIP Cyceron, F-14000 Caen, France; Department of Pathology, Caen University Hospital, Caen, France.
  • Elie N; Université de Caen-Normandie, Normandie Univ, Federative Structure 4207 "Normandie Oncologie", Service Unit PLATON, Virtual'His platform, Caen, France.
  • Creveuil C; Université de Caen-Normandie, Normandie Univ, Biomedical Research Unit, University Hospital, Caen, France.
  • Brosseau S; Université Paris Cité, Thoracic Oncology Department & CIC1425, Hôpital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France; U830 INSERM "Cancer, Heterogeneity, Instability, Plasticity, A.R.T group", Curie Institute, Paris, France.
  • Danel C; Université Paris Cité Department of Pathology, Hôpital Bichat-Claude Bernard, AP-HP, Paris, France.
  • Scherpereel A; Department of Pulmonary and Thoracic Oncology, Centre Hospitalier Universitaire Lille, University of Lille, U1019 INSERM, Center of Infection and Immunity of Lille, Lille, France.
  • Lantuejoul S; Department of Biopathology, Reference National Center MESOPATH, Centre Léon Bérard, Lyon, France.
  • Mazières J; Grenoble Alpes University, Department of Pulmonology, Hôpital Larrey, University Hospital of Toulouse, Toulouse, France.
  • Greillier L; Department of Multidisciplinary Oncology and Therapeutic Innovations, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
  • Audigier-Valette C; Department of Pulmonology, Centre Hospitalier Toulon Sainte-Musse, Toulon, France.
  • Bergot E; Université de Caen-Normandie, CNRS, Normandie Univ, ISTCT UMR6030, GIP Cyceron, F-14000 Caen, France; Normandie Univ, UNICAEN, Pulmonology and Thoracic Oncology Department, Caen University Hospital, Caen, France.
  • Moro-Sibilot D; Pôle Thorax et Vaisseaux, Centre Hospitalier Universitaire Grenoble, Grenoble, France.
  • Molinier O; Department of Pulmonology, Centre Hospitalier Le Mans, Le Mans, France.
  • Léna H; Department of Pulmonology, Ponchaillou University Hospital, Rennes, France.
  • Monnet I; Department of Pulmonology, CHI Créteil, Créteil, France.
  • Morin F; Intergroupe Francophone de Cancérologie Thoracique (IFCT), Paris, France.
  • Gounant V; Université Paris Cité, Thoracic Oncology Department & CIC1425, Hôpital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France; Pulmonology and thoracic oncology Department, Tenon University Hospital, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France.
  • Zalcman G; Université Paris Cité, Thoracic Oncology Department & CIC1425, Hôpital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France; U830 INSERM "Cancer, Heterogeneity, Instability, Plasticity, A.R.T group", Curie Institute, Paris, France. Electronic address: gerard.zalcma
Lung Cancer ; 182: 107287, 2023 08.
Article in En | MEDLINE | ID: mdl-37393757

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: France Country of publication: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: France Country of publication: Ireland